Results 111 to 120 of about 79,273 (259)

Pandemic (H1N1) 2009 Cases, Buenos Aires, Argentina

Emerging Infectious Diseases, 2010
To determine clinical and virologic characteristics of pandemic (H1N1) 2009 in Buenos Aires, Argentina, we conducted real-time reverse transcription-PCR on samples from patients with influenza-like illness, June 11-30, 2009. Of 513 patients tested, 54% were positive for influenza virus subtype H1N1.
Marcela Echavarría, Marcia Querci, Débora Marcone, Cristina Videla, Alfredo Martínez, Pablo Bonvehi, Guadalupe Carballal   +6 more
openaire   +3 more sources

Influenza Surveillance in the Central African Republic From 2015 to 2018 to Inform Vaccination and Treatment Strategies

Influenza and Other Respiratory Viruses, Volume 20, Issue 1, January 2026.
ABSTRACT Background Surveillance of influenza infections and virus characterisation are essential to guide prevention strategies. In the Central African Republic (CAR), data on influenza viruses are patchy and poorly documented. Objective To study the clinical, seasonal, genetic and phenotypic characteristics of influenza viruses circulating in the CAR
Giscard Francis Komoyo, Chantal J. Snoeck, Rod S. Daniels, Marie R. Belizaire, Judith M. Hübschen, Claude P. Muller, Pierre Somse, Yap Boum II, Emmanuel Nakoune, John W. McCauley   +9 more
wiley   +1 more source

Comparison of the Pathogenicity in Mice of A(H1N1)pdm09 Viruses Isolated between 2009 and 2015 in Japan

Viruses, 2020
The A(H1N1)pdm09 virus emerged in 2009 and continues to circulate in human populations. Recent A(H1N1)pdm09 viruses, that is, A(H1N1)pdm09 viruses circulating in the post-pandemic era, can cause more or less severe infections than those caused by the ...
Hiromichi Mitake, Atsuhiro Yasuhara, Tiago J. S. Lopes, Yuko Tagawa-Sakai, Kohei Shimizu, Hiroki Ozawa, Chiharu Kawakami, Saeko Morikawa, Norio Sugaya, Tokiko Watanabe, Yoshihiro Kawaoka   +10 more
doaj   +1 more source

International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1) pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE [PDF]

, 2015
The microneutralization assay is commonly used to detect antibodies to influenza virus, and multiple protocols are used worldwide. These protocols differ in the incubation time of the assay as well as in the order of specific steps, and even within ...
Engelhardt, OG, Heath, A, Hoschler, K, Hungnes, O, Katz, JM, Laurie, KL, Peiris, M, Van Kerkhove, MD, Wood, J, Zhang, W   +9 more
core   +1 more source

Clinical Characteristics and Cytokines of Children With Lower Respiratory Tract Infection Caused by Influenza A After COVID‐19

Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2026, Issue 1, 2026.
Background To date, there is a lack of research on the clinical characteristics and cytokine profiles in children with influenza A following COVID‐19 infection. Methods Children with influenza A lower respiratory tract infection who were hospitalized in the Department of Pediatrics of the Affiliated Hospital of Southwest Medical University from March ...
Yue Qi, Xinqian Xu, Hongrong Dan, Miao He, Qinxin Zheng, Xing Liu, Li Xiang, Yingshun Zhou, Cheng Li, Satabdi Datta Choudhury   +9 more
wiley   +1 more source

Pandemic (H1N1) 2009 Outbreak on Pig Farm, Argentina

Emerging Infectious Diseases, 2010
In June–July 2009, an outbreak of pandemic (H1N1) 2009 infection occurred on a pig farm in Argentina. Molecular analysis indicated that the virus was genetically related to the pandemic (H1N1) 2009 influenza virus strain. The outbreak presumably resulted
Ariel Pereda, Javier Cappuccio, María A. Quiroga, Elsa Baumeister, Lucas Insarralde, Mariela Ibar, Ramón Sanguinetti, Maria L. Cannilla, Débora Franzese, Oscar E. Escobar Cabrera, Maria I. Craig, Agustina Rimondi, Mariana Machuca, Rosa T. Debenedetti, Carlos Zenobi, Leonardo Barral, Rodrigo Balzano, Santiago Capalbo, Adriana Risso, Carlos J. Perfumo   +19 more
doaj   +1 more source

Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age [PDF]

, 2014
Background: Vaccines against pandemic A/H1N1 influenza should provide protective immunity in children, because they are at greater risk of disease than adults.
Abarca, Katia, Arora, Ashwani, Della Cioppa, Giovanni, Kieninger-Baum, Dorothee, Knuf, Markus, Lattanzi, Maria, Leroux-Roels, Geert, Pedotti, Paola, Rivera, Luis, Rümke, Hans C   +9 more
core   +2 more sources

National Level Response to Pandemic (H1N1) 2009

Journal of Preventive Medicine and Public Health, 2010
The World Health Organization (WHO) announced the emergence of a novel influenza on April 24, 2009, and they declared pandemic on June 11. In Korea, the proportion of influenza-like illness and the consumption of antiviral agents peaked in early November.
Dong Han, Lee, Sang Sook, Shin, Byung Yool, Jun, Jong Koo, Lee   +3 more
openaire   +2 more sources

Swine Influenza Virus Antibodies in Humans, Western Europe, 2009

Emerging Infectious Diseases, 2011
Serologic studies for swine influenza viruses (SIVs) in humans with occupational exposure to swine have been reported from the Americas but not from Europe.
Nancy A. Gerloff, Jacques R. Kremer, Emilie Charpentier, Aurélie Sausy, Christophe M. Olinger, Pierre Weicherding, John Schuh, Kristien Van Reeth, Claude P. Muller   +8 more
doaj   +1 more source

Serologic evidence of pandemic (H1N1) 2009 virus infection in camel and Eld's deer, Thailand. [PDF]

Vet World, 2021
Chaiwattanarungruengpaisan S, Ketchim N, Surarith W, Thongdee M, Prompiram P, Tonchiangsai K, Tipkantha W, Wiriyarat W, Paungpin W.   +8 more
europepmc   +1 more source